ACNP abstracts are available on the conference website and the Company’s poster will be available on the Centessa website at https://investors.centessa.com/events-presentations after the poster ...
Antidepressive effects and enhanced wakefulness were observed with OX2R activation in established animal model of major depressive disorder ...
Antidepressive effects and enhanced wakefulness were observed with OX2R activation in established animal model of major depressive disorderBOSTON and LONDON, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Centessa ...
Toad venom (Chansu), first documented in the "Yaoxing Lun" (Treatise on the Properties of Medicines), is a treasured ...
The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
New York City, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ...
Amazon Pharmacy maintains the requirement for a valid prescription as the central safeguard separating evidence-based medical ...
Medscape Medical News talked with researcher Stacie Dusetzina about the prospects for a single-payer program to help with the ...
WAKIX 2025 Preliminary Net Revenue of ~$868 Million; 2026 WAKIX Net Revenue Guidance of $1.0 – $1.04 Billion on Track for Blockbuster Status in NarcolepsyOn Track to Extend the Pitolisant Franchise ...
Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...
To sum up, GH001 has shown us pretty robust efficacy, a strong safety profile, and durable antidepressant effects. Going into tomorrow, it has compelling Phase 2b and open-label extension data. Now, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback